News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
890,985 Results
Type
Article (89290)
Company Profile (559)
Press Release (801109)
Multimedia
Podcasts (264)
Webinars (41)
Section
Business (267278)
Career Advice (4173)
Deals (40084)
Drug Delivery (207)
Drug Development (91948)
Employer Resources (209)
FDA (18678)
Job Trends (17526)
News (399252)
Policy (40036)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3084)
Academic (2)
Accelerated approval (68)
ADA (51)
Adcomms (44)
Allergies (220)
Alliances (56993)
ALS (258)
Alzheimer's disease (2085)
Antibody-drug conjugate (ADC) (658)
Approvals (19147)
Artificial intelligence (1017)
ASCO (345)
Autoimmune disease (430)
Automation (73)
Bankruptcy (412)
Belgium (5)
Best Places to Work (12635)
BIO (81)
Biologics (14)
BIOSECURE Act (23)
Biosimilars (280)
BioSpace Insights (250)
Biotechnology (338)
Bispecific (1)
Bladder cancer (229)
Brain cancer (93)
Breast cancer (904)
Cancer (7250)
Cardiovascular disease (626)
Career advice (3619)
Career pathing (60)
CAR-T (420)
CDC (77)
CDMO (168)
Celiac Disease (4)
Cell therapy (1164)
Cervical cancer (61)
Clinical research (80024)
Collaboration (2644)
Commercialization (12)
Company closure (10)
Compensation (1768)
Complete response letters (123)
COVID-19 (3058)
CRISPR (137)
C-suite (1542)
Cystic fibrosis (175)
Data (9641)
Decentralized trials (3)
Denatured (103)
Depression (214)
Dermatology (129)
Diabetes (761)
Diagnostics (7790)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (512)
Drug pricing (250)
Drug shortages (39)
Duchenne muscular dystrophy (362)
Earnings (103687)
Editorial (83)
Employer branding (25)
Employer resources (179)
Events (140030)
Executive appointments (1311)
FDA (23314)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2177)
Gene editing (296)
Generative AI (102)
Gene therapy (916)
GLP-1 (1338)
Government (5600)
Grass and pollen (8)
Guidances (435)
Healthcare (21383)
Hematology (198)
HIV (113)
Huntington's disease (76)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (131)
Immunology and inflammation (394)
Immuno-oncology (140)
Indications (245)
Infectious disease (3487)
Inflammatory bowel disease (251)
Inflation Reduction Act (17)
Influenza (159)
Intellectual property (360)
Interviews (826)
IPO (18042)
IRA (61)
Job creations (5211)
Job search strategy (2879)
JPM (73)
Kidney cancer (28)
Labor market (135)
Layoffs (711)
Leadership (59)
Legal (10176)
Licensing (27)
Liver cancer (115)
Longevity (43)
Lung cancer (981)
Lymphoma (518)
Machine learning (74)
Management (70)
Manufacturing (1447)
Marketing (14)
MASH (240)
Medical affairs (3)
Medical device (15409)
Medtech (15670)
Mergers & acquisitions (23501)
Metabolic disorders (1970)
mRNA (305)
Multiple sclerosis (225)
Multispecific (1)
NASH (24)
Netherlands (5)
Neurodegenerative disease (575)
Neuropsychiatric disorders (144)
Neuroscience (4052)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5161)
Now hiring (91)
Obesity (932)
Opinion (395)
Ovarian cancer (263)
Pain (318)
Pancreatic cancer (402)
Parkinson's disease (455)
Partnered (47)
Patents (753)
Patient advocacy (1)
Patient recruitment (943)
Patient selection (1)
Peanut (73)
People (68650)
Peptides (5)
Pharmaceutical (82)
Pharmacy benefit managers (40)
Phase 1 (24697)
Phase 2 (34722)
Phase 3 (26177)
Pipeline (12153)
Policy (415)
Postmarket research (3561)
Preclinical (11055)
Press Release (72)
Prostate cancer (377)
Psychedelics (88)
Radiopharmaceuticals (410)
Rare diseases (1467)
Real estate (7473)
Recruiting (83)
Regulatory (31257)
Reports (91)
Research institute (2802)
Resumes & cover letters (656)
Rett syndrome (52)
RNA editing (33)
RSV (102)
Schizophrenia (210)
Series A (370)
Series B (269)
Service/supplier (16)
Sickle cell disease (138)
Special edition (34)
Spinal muscular atrophy (196)
Sponsored (57)
Startups (4388)
State (2)
Stomach cancer (22)
Supply chain (157)
Tariffs (105)
The Weekly (158)
Vaccines (1386)
Venture capital (160)
Weight loss (628)
Women's health (163)
Worklife (26)
Date
Today (37)
Last 7 days (679)
Last 30 days (2334)
Last 365 days (33423)
2026 (23611)
2025 (33213)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1301)
Alabama (111)
Alaska (7)
Arizona (454)
Arkansas (16)
Asia (52781)
Australia (9290)
California (15844)
Canada (4420)
China (1833)
Colorado (674)
Connecticut (707)
Delaware (490)
Europe (121743)
Florida (2409)
Georgia (520)
Hawaii (5)
Idaho (70)
Illinois (1376)
India (132)
Indiana (718)
Iowa (30)
Japan (695)
Kansas (151)
Kentucky (65)
Louisiana (68)
Maine (95)
Maryland (1900)
Massachusetts (11529)
Michigan (454)
Minnesota (875)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (173)
New Hampshire (92)
New Jersey (4172)
New Mexico (38)
New York (4153)
North Carolina (2091)
North Dakota (11)
Northern California (7996)
Ohio (505)
Oklahoma (31)
Oregon (49)
Pennsylvania (3047)
Puerto Rico (33)
Rhode Island (56)
South America (1672)
South Carolina (96)
South Dakota (2)
Southern California (6282)
Tennessee (264)
Texas (2598)
United States (56403)
Utah (476)
Vermont (2)
Virginia (399)
Washington D.C. (88)
Washington State (1284)
West Virginia (4)
Wisconsin (179)
Wyoming (4)
There are 890,985 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial
September 14, 2026
·
19 min read
Press Releases
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
September 14, 2026
·
19 min read
Press Releases
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
September 14, 2026
·
19 min read
Press Releases
Johnson & Johnson’s RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer
September 14, 2026
·
32 min read
Cancer
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
Following their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized cancer vaccines. Here are five companies with similar therapies hoping to break through where others have previously failed.
September 14, 2026
·
9 min read
·
Tristan Manalac
mRNA
After a brief storm of political headwinds, mRNA is back with strong momentum
A year to the day after the Trump administration slashed $500 million in funding from mRNA-based programs, the FDA approved Moderna’s flu vaccine based on the technology. Weeks later, Moderna and Merck revealed positive Phase 3 results for their personalized mRNA-based cancer vaccine. In the words of one mRNA specialist, “science won.”
September 14, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE’s “Caring Plan-Extension” Pilot Program for Rare Disease Drug Development
September 13, 2026
·
2 min read
Press Releases
Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
September 13, 2026
·
7 min read
Press Releases
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 11, 2026
September 13, 2026
·
2 min read
Press Releases
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
September 13, 2026
·
12 min read
1 of 89,099
Next
